X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-25 | VRCA | Rosenberg Noah L. | CMO | P - Purchase | $4.24 | +2,357 | 2,357 | New | +$10,000 | |||||
| D | 2025-11-25 | VRCA | Kirby John J. | Interim CFO | P - Purchase | $4.24 | +3,536 | 8,962 | +65% | +$15,001 | |||||
| D | 2025-11-25 | VRCA | Zawitz David | COO | P - Purchase | $4.24 | +10,000 | 21,000 | +91% | +$42,425 | |||||
| D | 2025-11-25 | VRCA | Rieger Jayson | CEO, Pres | P - Purchase | $4.24 | +94,311 | 183,298 | +106% | +$400,114 | |||||
| D | 2025-11-25 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $4.24 | +4,126,142 | 7,932,218 | +108% | +$17,505,157 | |||||
| D | 2025-03-17 | VRCA | Hayes Christopher G. | GC | S - Sale+OE | $0.65 | -4,315 | 176,458 | -2% | -$2,805 | |||||
| D | 2024-11-22 | VRCA | Rieger Jayson | CEO, Pres | P - Purchase | $0.00 | +280,898 | 889,881 | +46% | +$0 | |||||
| D | 2024-11-22 | VRCA | Stalfort John A III | Dir | P - Purchase | $0.00 | +1,123,595 | 1,873,800 | +150% | +$0 | |||||
| D | 2024-11-22 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $0.00 | +22,921,348 | 38,060,779 | +151% | +$0 | |||||
| M | 2024-08-26 | VRCA | Hayes Christopher G. | GC | S - Sale | $2.61 | -35,713 | 105,773 | -25% | -$93,091 | |||||
| M | 2024-08-26 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $2.61 | -13,489 | 94,261 | -13% | -$35,161 | |||||
| M | 2024-08-26 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $2.61 | -33,702 | 73,114 | -32% | -$87,849 | |||||
| M | 2024-08-26 | VRCA | Kohler Terry | CFO | S - Sale | $2.61 | -29,719 | 44,697 | -40% | -$77,473 | |||||
| M | 2024-08-26 | VRCA | White Ted | Pres, CEO | S - Sale | $2.61 | -34,000 | 215,967 | -14% | -$88,636 | |||||
| M | 2024-07-22 | VRCA | White Ted | Pres, CEO | S - Sale | $7.06 | -32,623 | 249,967 | -12% | -$230,306 | |||||
| M | 2024-07-22 | VRCA | Bonaccorso Joe | Chief Commercial Officer | S - Sale | $7.06 | -25,576 | 106,816 | -19% | -$180,557 | |||||
| M | 2024-07-22 | VRCA | Goldenberg Gary | Chief Medical Officer | S - Sale | $7.06 | -18,507 | 107,750 | -15% | -$130,653 | |||||
| M | 2024-07-22 | VRCA | Hayes Christopher G. | GC | S - Sale | $7.06 | -21,740 | 141,486 | -13% | -$153,477 | |||||
| M | 2023-12-27 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $7.17 | +321,616 | 7,099,182 | +5% | +$2,305,132 | |||||
| M | 2023-12-21 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $6.45 | +504,652 | 6,777,566 | +8% | +$3,256,191 | |||||
| M | 2023-12-15 | VRCA | Perceptive Advisors LLC | 10% | P - Purchase | $5.63 | +1,233,931 | 6,272,914 | +24% | +$6,941,716 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |